UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

European journal of cancer (1990), 2013-01, Vol.49 (1), p.90-97

2013

Volltextzugriff (PDF)

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials

Annals of oncology, 2012-01, Vol.23 (1), p.86-93

2012

Volltextzugriff (PDF)

Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

Lung cancer (Amsterdam, Netherlands), 2014-03, Vol.83 (3), p.383-388

2014

Volltextzugriff (PDF)

Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution

Annals of oncology, 2002-02, Vol.13 (2), p.267-272

2002

Volltextzugriff (PDF)

SP-010: Update of the meta-analysis of chemotherapy in head and neck cancer (MACH-NC)

Radiotherapy and oncology, 2017-03, Vol.122, p.9-9

2017

Volltextzugriff (PDF)

PD-028: Prognostic and predictive impact of HPV status in oropharyngeal cancer: the MARCH-HPV project

Radiotherapy and oncology, 2017-03, Vol.122, p.17-17

2017

Volltextzugriff (PDF)

3025 Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT)

European journal of cancer (1990), 2015-09, Vol.51, p.S604-S604

2015

Volltextzugriff (PDF)

3130 Prognostic value of ALK gene copy number in advanced Non Small Cell Lung Cancer (NSCLC) patients

European journal of cancer (1990), 2015-09, Vol.51, p.S646-S647

2015

Volltextzugriff (PDF)

What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups

European journal of cancer (1990), 2017, Vol.72, p.S101-S102

2017

Volltextzugriff (PDF)

OC-003: What is the best treatment in nasopharyngeal carcinoma? An individual patient data network meta-analysis

Radiotherapy and oncology, 2015-02, Vol.114, p.6-7

2015

Volltextzugriff (PDF)

3000 Chemo-radiation (CRT) and mutation profile in stage III Non Small Cell Lung Cancer (NSCLC): An analysis of the prognostic value

European journal of cancer (1990), 2015-09, Vol.51, p.S595-S595

2015

Volltextzugriff (PDF)

3081 Molecular Tumor Board (MTB) in non-small cell lung cancers (NSCLC) to optimize targeted therapies: 4 years' experience at Gustave Roussy

European journal of cancer (1990), 2015-09, Vol.51, p.S624-S624

2015

Volltextzugriff (PDF)

OC-0057: Meta-analysis of radiotherapy in head and neck cancers: exploratory analysis according to patient characteristics

Radiotherapy and oncology, 2014, Vol.111, p.S21-S21

2014

Volltextzugriff (PDF)

192 speaker UPDATE ON RANDOMIZED TRIALS AND META-ANALYSES CONCERNING INDUCTION VERSUS CONCOMITANT RADIOCHEMOTHERAPY IN LUNG CANCER

Radiotherapy and oncology, 2011, Vol.99, p.S75-S75

2011

Volltextzugriff (PDF)

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

Annals of oncology, 2016-10, Vol.27 (10), p.1818-1828

2016

Volltextzugriff (PDF)

Reply to: Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011-02, Vol.23 (1), p.62-63

2011

Volltextzugriff (PDF)

OC-06: Evaluation of Toxicities of Target Therapy Phase I/II Trials on Glioblastoma Multiforme Patients: A Meta-Analysis

Radiotherapy and oncology, 2012-09, Vol.104, p.22-22

2012

Volltextzugriff (PDF)

Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses

Journal of clinical epidemiology, 2005-03, Vol.58 (3), p.238-245

2005

Volltextzugriff (PDF)

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial

Annals of oncology, 2013-11, Vol.24 (11), p.2834-2838

2013

Volltextzugriff (PDF)

Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients

European journal of cancer (1990), 2019-02, Vol.108, p.88-96

2019

Volltextzugriff (PDF)

Resection of liver metastases from colorectal cancer: the real impact of the surgical margin

European journal of surgical oncology, 1998-06, Vol.24 (3), p.174-179

1998

Volltextzugriff (PDF)

Concomitant versus neoadjuvant chemotherapy for patients with locally advanced head and neck cancer. Results of two individual patient data meta-analyses

Radiotherapy and oncology, 2007, Vol.82, p.S9-S9

2007

Volltextzugriff (PDF)

ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA

European journal of cancer (1990), 2022-05, Vol.166, p.112-125

2022

Volltextzugriff (PDF)

Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer—A definite conclusion?

Seminars in oncology, 2017-04, Vol.44 (2), p.129-131

2017

Volltextzugriff (PDF)

How individual participant data meta-analyses have influenced trial design, conduct, and analysis

Journal of clinical epidemiology, 2015-11, Vol.68 (11), p.1325-1335

2015

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(31)
Humans
(29)
Oncology
(27)
Female
(22)
Male
(21)
Hematology, Oncology And Palliative Medicine
(19)
Middle Aged
(18)
Aged
(16)
Adult
(14)
Biological And Medical Sciences
(13)
Chemotherapy
(13)
Medical Sciences
(13)
Disease-Free Survival
(12)
Combined Modality Therapy
(8)
Meta-Analysis
(8)
Pharmacology. Drug Treatments
(8)
Antineoplastic Agents
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Prognosis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials

Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution

SP-010: Update of the meta-analysis of chemotherapy in head and neck cancer (MACH-NC)

PD-028: Prognostic and predictive impact of HPV status in oropharyngeal cancer: the MARCH-HPV project

3025 Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT)

3130 Prognostic value of ALK gene copy number in advanced Non Small Cell Lung Cancer (NSCLC) patients

What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups

OC-003: What is the best treatment in nasopharyngeal carcinoma? An individual patient data network meta-analysis

3000 Chemo-radiation (CRT) and mutation profile in stage III Non Small Cell Lung Cancer (NSCLC): An analysis of the prognostic value

3081 Molecular Tumor Board (MTB) in non-small cell lung cancers (NSCLC) to optimize targeted therapies: 4 years' experience at Gustave Roussy

OC-0057: Meta-analysis of radiotherapy in head and neck cancers: exploratory analysis according to patient characteristics

192 speaker UPDATE ON RANDOMIZED TRIALS AND META-ANALYSES CONCERNING INDUCTION VERSUS CONCOMITANT RADIOCHEMOTHERAPY IN LUNG CANCER

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

Reply to: Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence

OC-06: Evaluation of Toxicities of Target Therapy Phase I/II Trials on Glioblastoma Multiforme Patients: A Meta-Analysis

Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial

Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients

Resection of liver metastases from colorectal cancer: the real impact of the surgical margin

Concomitant versus neoadjuvant chemotherapy for patients with locally advanced head and neck cancer. Results of two individual patient data meta-analyses

ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA

Angiogenesis inhibition in the second-line treatment of metastatic colorectal cancer—A definite conclusion?

How individual participant data meta-analyses have influenced trial design, conduct, and analysis

Suchergebnisse filtern